SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Pilepich MV, Krall JM, Al-Sarraf M et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma. a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 1995; 45: 61623
  • 2
    Syed S, Petrylak DP, Thompson IM. Management of high-risk localized prostate cancer: the integration of local and systemic therapy approaches. Urol Oncol 2003; 21: 23543
  • 3
    Seidenfeld J, Samson DJ, Aronson N et al. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. Evid Rep Technol Assess (Summ) 1999; 4: 1246
  • 4
    National Cancer Institute. Stage III Prostate Cancer. Prostate Cancer PDQ®: Treatment, December 8, 2005. Available at: http://www.nci.nih.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/page7. Accessed March 2006
  • 5
    Southwest Oncology Group. S9921 – Phase III intergroup. Adjuvant androgen deprivation versus mitoxantrone plus prednisone plus androgen deprivation in selected high risk prostate cancer patients following radical prostatectomy, phase III, 1999. Available at: http://www.swog.org/Visitors/ViewProtocolDetails.asp?ProtocolID=64. Accessed March 2006
  • 6
    Department of Veterans Affairs. CSP ♯553 Chemotherapy after prostatectomy (CAP) for high risk prostate carcinoma. A phase III randomized study. Clinical Trials.gov identifier: NCT00132301. Available at: http://www.clinicaltrials.gov/ct/show/NCT00132301. Accessed March 2006
  • 7
    Gerber GS, Thisted RA, Chodak GW et al. Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. Eur Urol 1997; 32: 38590
  • 8
    Van Poppel H, Goethuys H, Callewaert P, Vanuytsel L, Van de Voorde W, Baert L. Radical prostatectomy can provide a cure for well-selected clinical stage T3 prostate cancer. Eur Urol 2000; 38: 3729
  • 9
    Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280: 16901
  • 10
    Denberg TD, Beaty BL, Kim FJ, Steiner JF. Marriage and ethnicity predict treatment in localized prostate carcinoma. Cancer 2005; 103: 181925
  • 11
    Hoffman RM, Harlan LC, Klabunde CN et al. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med 2003; 18: 84553
  • 12
    Jancin B. Radiation improves advanced prostate cancer’s outcomes. In Internal Medicine News, Vol. 38 (22). Morristown, NJ: Elsevier, 2005: 1, 6
  • 13
    Powell IJ, Tangen CM, Miller GJ et al. Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109. J Urol 2002; 168: 20169
  • 14
    Soloway MS, Pareek K, Sharifi R et al. Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results. J Urol 2002; 167: 1126
  • 15
    Aus G, Abrahamsson PA, Ahlgren G et al. Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial. BJU Int 2002; 90: 5616
  • 16
    Bono AV, Pagano F, Montironi R et al. Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: progress pathology report of the Italian PROSIT study. Urology 2001; 57: 11721
  • 17
    Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005; 95: 7516
  • 18
    Akakura K, Isaka S, Akimoto S et al. Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities. Urology 1999; 54: 3138
  • 19
    Baxter NN, Tepper JE, Durham SB, Rothenberger DA, Virnig BA. Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 2005; 128: 81924
  • 20
    Movsas B, Hanlon AL, Pinover W, Hanks GE. Is there an increased risk of second primaries following prostate irradiation? Int J Radiat Oncol Biol Phys 1998; 41: 2515